Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plano Lens Cosmetics Classification Countered In Boozman-Waxman Bill

This article was originally published in The Gray Sheet

Executive Summary

Legislation co-sponsored by Reps. Henry Waxman (D-Calif.) and House optometrist John Boozman (R-Ark.) targets alleged loopholes created by FDA's decision to regulate noncorrective contact lenses as cosmetics rather than medical devices

You may also be interested in...



Contact Lens Prescription Bill Would Require FTC Study Of Verification Laws

Factors affecting competition within the prescription contact lens industry would be explored by the Federal Trade Commission under a bill to be considered by the House Energy & Commerce/Consumer Protection Subcommittee Sept. 9

Contact Lens Prescription Bill Would Require FTC Study Of Verification Laws

Factors affecting competition within the prescription contact lens industry would be explored by the Federal Trade Commission under a bill to be considered by the House Energy & Commerce/Consumer Protection Subcommittee Sept. 9

Optometrists, Legislators Push For Stronger FDA Oversight Of Contact Lenses

Legislation addressing the regulation of decorative contact lenses has a strong chance of being considered this fall when Congress returns from its August recess, according to staffers

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018473

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel